Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Vidofludimus calcium by Immunic for Primary Progressive Multiple Sclerosis (PPMS): Likelihood of Approval
Vidofludimus calcium is under clinical development by Immunic and currently in Phase II for Primary Progressive Multiple Sclerosis (PPMS). According...